Human polyomavirus 1
| Brincidofovir | BKV | Viral DNA polymerase inhibitor | Phase 3 | — | Viral DNA pol | |
| Artesunate | BKV | Unclear | Preclinical | — | Unknown | |
| Bexarotene | BKV | Unknown | Preclinical | — | Human RAR | |
| Bithionol | BKV | Uncoupler of oxidative phosphorylation | Preclinical | — | Unknown | |
| Cidofovir | BKV | Viral DNA polymerase inhibitor | Phase 2 | — | Viral DNA pol | |
| Erlotinib | BKV | EGFR inhibitor | Preclinical | — | Human PTK | |
| Gefitinib | BKV | EGFR inhibitor | Preclinical | — | Human PTK | |
| Hexachlorophene | BKV | — | Preclinical | — | Unknown | |
| Imatinib | BKV | Abl; Kit; PDGFRB inhibitor | Preclinical | — | Human PTK | |
| Ivermectin | BKV | Importin-mediated nuclear import inhibitor | Preclinical | — | Human importin | |
| Leflunomide | BKV | Pyrimidine synthesis inhibitor | Preclinical | — | Human DHODH | |
| Mycophenolic acid | BKV | Inosine monophosphate dehydrogenase inhibitor | Preclinical | — | Human IMPDH | |
| Sunitinib | BKV | Broad TK inhibitor | Preclinical | — | Human PTK | |
| Verdinexor | BKV | Nuclear export inhibitor | Preclinical | — | Human exportin | |
| Vidarabine | BKV | Viral DNA synthesis inhibitor | Approved (other) | Japan | Viral DNA pol |